Community Research and Development Information Service - CORDIS

  • European Commission
  • CORDIS
  • Projects and Results
  • Exploring decaprenyl-phosphoryl ribose epimerase (DprE1) as a validated target for TB drug discovery: Assay development, high-throughput screening and search for novel DprE1 inhibitor scaffolds

Exploring decaprenyl-phosphoryl ribose epimerase (DprE1) as a validated target for TB drug discovery: Assay development, high-throughput screening and search for novel DprE1 inhibitor scaffolds

From 2010-05-01 to 2012-04-30, closed project

Project details

Total cost:

EUR 174 065,20

EU contribution:

EUR 174 065,20

Coordinated in:

Switzerland

Call for proposal:

FP7-PEOPLE-2009-IIFSee other projects for this call

Funding scheme:

MC-IIF - International Incoming Fellowships (IIF)

Objective

Coordinator

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland

EU contribution: EUR 174 065,20


BATIMENT CE 3316 STATION 1
1015 LAUSANNE
Switzerland
Activity type: Higher or Secondary Education Establishments
Administrative contact: Stewart T. Cole
Tel.: +41 21 6931851
Fax: +41 21 6931790
E-mail
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top